Soluble Fas affects erythropoiesis in vitro and acts as a potential predictor of erythropoiesis-stimulating agent therapy in patients with chronic kidney disease

Serum soluble Fas (sFas) levels are associated with erythropoietin (Epo) hyporesponsiveness in patients with chronic kidney disease (CKD). Whether sFas could predict the need for erythropoiesis-stimulating agent (ESA) usage and its influence in erythropoiesis remain unclear. We evaluated the relatio...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Am J Physiol Renal Physiol
Hauptverfasser: Chiloff, Daniela Mendes, de Almeida, Danilo Candido, Dalboni, Maria A., Canziani, Maria Eugênia, George, Sunil K., Morsi, Alshaimaa Mahmoud, El-Akabawy, Nadia, Porada, Christopher D., Durao, Marcelino Souza, Zarjou, Abolfazl, Almeida-Porada, Graca, Goes, Miguel Angelo
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Physiological Society 2020
Schlagworte:
Research Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7474254/
https://ncbi.nlm.nih.gov/pubmed/32003597
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajprenal.00433.2019
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge